“A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial” (2026) Archivio Italiano di Urologia e Andrologia [Preprint]. doi:10.4081/aiua.2026.14712.